DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
Clinical trial NCT04106115 · RECRUITING
Trial details
- NCT number
- NCT04106115
- Sponsor
- University College, London
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-25
- Primary completion
- 2027-03-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.